La cadena de opciones muestra datos clave de las opciones de acciones de Tivic Health Systems a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Tivic Health Systems..

Tivic Health Systems (NASDAQ:TIVC) Bolsa, Cadena de Opciones

Tivic Health Systems

Tivic Health Systems Inc is a health technology company focused on developing and commercializing non-invasive bioelectronic medicine. The company's platform-based technology activates the body's own healing mechanisms and can be programmed to treat various disease conditions. company's products provide a natural alternative to the standard synthetic chemical methods used by the pharmaceutical industry. ClearUP Sinus Relief, is a first commercial product of the company which is a patented handled device that uses ultra-low current electrical waves to relieve sinus pain and congestion symptoms that are prevalent in nasal allergies, sinus infections, chronic sinusitis, cold and flu and other disease conditions.

KB Home

Earnings

News

Pre-Market Outlook

Markets

Trading Ideas

CTRM

EPAC

LUNR

TIVC

Aquí tienes cinco acciones estadounidenses que podrían llamar la atención de los inversores este lunes: KBH, TIVC, LUNR, CTRM y EPAC.

5 acciones en el foco este lunes: KBH, TIVC, LUNR, CTRM y EPAC

Movers

AMPG

AVGR

BIPC

CHEK

CREV

FDSB

HSDT

KORE

LAES

LIND

NCRA

NEUE

NVNI

RELI

SLGL

TLRY

TOVX

Carbon Revolution lidera con un aumento del 62,4% en el premercado. ¿Qué otras acciones destacaron antes de la apertura?

Las acciones de Carbon Revolution (CREV) están subiendo un 62%; 20 acciones que se están moviendo en el premercado

Tivic Health Systems, Inc. - Common stock

Tivic Health Systems Inc

Press Releases

Tivic Health Completes Optimization Study for Its Non-Invasive Vagus Nerve Stimulation Device

Tivic Shareholders Approve Key Proposals in Support of Strategic Transformation; Lisa Wolf Appointed Permanent CFO

Tivic Health to Report Second Quarter 2025 Financial Results on August 14th Via Conference Call and Webcast

Tivic Reports Second Quarter 2025 Financial Results

Tivic Health Advances Discussions on Use of Entolimod as a Radiation Countermeasure at Military Health System Research Symposium 2025

Tivic Receives Two Investigational New Drug Applications for Entolimod™ for the Treatment of Acute Radiation Syndrome (ARS) and Advanced Cancers

Tivic Completes Verification of Entolimod™ Cell Line: First Step in Establishing CGMP Manufacturing for BLA Filing

Tivic Health CEO Jennifer Ernst to Present at Emerging Growth's September Virtual Conference

Presenting on Emerging Growth Conference 86 Day 1 on September 24; Register to live stream

Presenting on Emerging Growth Conference 86 Day 2 September 25; Register to live stream

Comments

Tivic Health Systems

Tivic Health Systems (TIVC) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL